Buy & Sell Akamai Technologies, Inc. (AKAM) – Akamai Technologies, Inc. Price Today
Aura AI Summary
Key Stats
- $21.57BMarket Cap
- TechnologySector
- -25.44%3M Drawdown
- $26.50BEnterprise Value
- -Dividend Yield
- 58% Buy | 42% SellTrading Activity
- 46 daysTypical Hold Time
Akamai Technologies, Inc. (AKAM) is currently valued at a market capitalization of $21.57B, with an enterprise value of $26.50B. Over the past 52 weeks, Akamai Technologies, Inc. has traded between a low of $70.53 and a high of $153.01, highlighting its annual price range. Over the past three months, Akamai Technologies, Inc. has recorded a drawdown of -25.44%, reflecting recent price volatility. On average, investors hold Akamai Technologies, Inc. for approximately 46 days, indicating typical investor behavior on the platform.
About Akamai Technologies, Inc.
Akamai operates a content delivery network, or CDN, which entails locating servers at the edges of networks so its customers, which store content on Akamai servers, can reach their own customers faster, more securely, and with better quality. Akamai has over 325,000 servers distributed over 4,000 points of presence in more than 1,000 cities worldwide. Its customers generally include media companies, which stream video content or make video games available for download, and other enterprises that run interactive or high-traffic websites, such as e-commerce firms and financial institutions. Akamai also has a significant security business, which is integrated with its core web and media businesses to protect its customers from cyberthreats.
Most Recent News
Hampton Financial buys 10% stake in dry bulk shipping firm Icon Energy for C$550,000.
Hampton Financial Corporation has acquired a 10% stake in Icon Energy Corp, a dry bulk shipping company, through open market purchases totaling approximately C$550,000. Icon Energy operates three dry bulk vessels globally and is listed on Nasdaq. Ham...
Oil giants' trading desks boost Q1 profits amid volatile markets and geopolitical tensions.
In the first quarter, major oil companies like TotalEnergies, Shell, and BP saw significant profit boosts from their trading desks, which manage physical oil and gas transactions and price risks. These trading units thrived amid volatile oil prices c...
Roche gets CE mark for blood test detecting Alzheimer's pathology, enabling faster, less invasive diagnosis worldwide.
Roche has received CE Mark approval for Elecsys® pTau217, a blood test that detects phosphorylated Tau 217 protein linked to Alzheimer's disease pathology. This test offers a minimally invasive, accurate alternative to current diagnostic methods like...